Histopathological differences between human T-lymphotropic virus type 1-positive and human T-lymphotropic virus type 1-negative polymyositis

Clinical and Experimental Neuroimmunology

Volumn 2, Issue 1, 2011, Pages 12-24

  Abdullah, Hazem M ^a,b   Higuchi, Itsuro ^c   Kubota, Ryuji ^a   Matsuura, Eiji ^c   Hashiguchi, Akihiro ^c   Abdelbary, Nashwa H ^a   Inamori, Yukie ^c   Takashima, Hiroshi ^c   Izumo, Shuji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b MANSOURA UNIVERSITY   (Egypt)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cytochrome c oxidase; Human T lymphotropic virus type 1; Mitochondrial abnormality; Polymyositis

Indexed keywords

DNA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOCHROME C OXIDASE DEFICIENCY; DNA EXTRACTION; ELECTRON MICROSCOPY; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; MUSCLE BIOPSY; MYOSITIS; NONHUMAN; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SKELETAL MUSCLE; VIRUS LOAD; VIRUS MORPHOLOGY;

EID: 79952061853     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/j.1759-1961.2011.00017.x     Document Type: Article

References (29)

1. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986; 327: 1031-2. (Pubitemid 16102987)
2. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997; 15: 15-37. (Pubitemid 27169273)
3. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet. 1989; 334: 1184-7.
4. Dalakas MC. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects. Rev Neurol. 2002; 158: 948-58. (Pubitemid 35303628)
5. Dalakas MC. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology. 2006; 66: 33-8.
6. Matsuura E, Umehara F, Nose H, Higuchi I, Matsuoka E, Izumi K, et al. Inclusion body myositis associated with human T-lymphotropic virus-Type I infection: eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol. 2008; 67: 41-9.
7. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003; 362: 971-82. (Pubitemid 37159295)
8. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med. 1991; 325: 1487-98.
9. Dubowitz V, Brooke MH. The procedure of muscle biopsy. Muscle Biopsy: A Modern Approach. Dubowitz V, Brooke MH, Neville HE, eds. London, Philadelphia, Toronto: WB Saunders; 1973: 5-102.
10. Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruyama I, Osame M, et al. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol. 1993; 42: 147-54. (Pubitemid 23045884)
11. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM?TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM?TSP. J Neurovirol. 1998; 4: 586-93. (Pubitemid 29042065)
12. Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003; 61: 288-90. (Pubitemid 36975952)
13. Van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, Van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003; 6: 316-21. (Pubitemid 36975958)
14. Dalakas MC. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol. 2004; 17: 561-7. (Pubitemid 39410872)
15. Gessain A. Epidemiology of HTLV-1 and associated diseases. Human T-cell Lymphotropic Virus Type-1. Höllsberg P, Hafler DA, eds. Chiester: Wiley; 1997: 33-64.
16. Higuchi I, Nerenberg M, Yoshimine K, Yoshida M, Fukunaga H, Tajima K, et al. Failure to detect HTLV-I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis. Muscle Nerve. 1992; 15: 43-7.
17. Higuchi I, Hashimoto K, Kashio N, Izumo S, Inose M, Izumi K, et al. Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle Nerve. 1995; 18: 854-8.
18. Gilbert DT, Morgan O, Smikle MF, Simeon D, Barton EN. HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand. 2001; 104: 101-4. (Pubitemid 32977011)
19. Higuchi I, Hashimoto K, Matsuoka E, Rosales R, Nakagawa M, Arimura K, et al. The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes. Acta Neuropathol. 1996; 92: 358-61. (Pubitemid 26317102)
20. Saito M, Higuchi I, Saito A, Izumo S, Usuku K, Bangham CR, et al. Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis. 2002; 186: 1231-41. (Pubitemid 35193001)
21. Ozden S, Gessain A, Gout O, Mikol J. Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy. Clin Infect Dis. 2001; 32: 510-4. (Pubitemid 32173642)
22. Ozden S, Cochet M, Mikol J, Teixeira A, Gessain A, Pique C. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia?lymphoma virus type 1-infected patient with sporadic inclusion body myositis. J Virol. 2004; 78: 10320-7. (Pubitemid 39258357)
23. Kohsaka H. Current insights in polymyositis and dermatomyositis. Clin and Exp Neuroimmunol. 2010; 1: 22-32.
24. Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993; 52: 424-30. (Pubitemid 23199203)
25. Mochizuki M. Regional immunity of the eye. Acta Ophthalmol. 2010; 88: 292-9.
26. Ciminale V, Zotti L, D'Agostino DM, Ferro T, Casareto L, Franchini G, et al. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia?lymphotropic virus type I (HTLV-I). Oncogene. 1999; 18: 4505-14. (Pubitemid 29396658)
27. Nicot C, Harrod RL, Ciminale V, Franchini G. Human T-cell leukemia?lymphoma virus type 1 nonstructural genes and their functions. Oncogene. 2005; 24: 6026-34. (Pubitemid 43086120)
28. Chariot P, Monnet I, Gherardi R. Cytochrome C oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann Neurol. 1993; 34: 561-5. (Pubitemid 23289407)
29. II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J Biol Chem. 2002; 277: 34424-33.